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ABSTRACT 
 Two 21-year old dizygotic twin men of Iraqi descent were homozygous for HBB codon 8, 
deletion of 2 nucleotides (–AA) frame-shift β0
 
-thalassaemia mutation (FSC8; HBB:c25_26delAA).  
Both were clinically well, had splenomegaly, and were never transfused.  They had mild 
microcytic anaemia (Hb 120-130 g/l) and 98% of their haemoglobin was fetal haemoglobin 
(HbF).  Both were carriers of Hph α-thalassaemia mutation.  On the 3 major HbF quantitative 
trait loci (QTL), the twins were homozygous for G>A HBG2 Xmn1 site at single nucleotide 
polymorphism (SNP) rs7482144, homozygous for 3-bp deletion HBS1L-MYB intergenic 
polymorphism (HMIP) at rs66650371, and heterozygous for the A>C BCL11A intron 2 
polymorphism at rs766432.  These findings were compared with those found in 22 other FSC8 
homozygote patients: 4 presented with thalassaemia intermedia phenotype, and 18 were 
transfusion dependent.  The inheritance of homozygosity for HMIP 3-bp deletion at rs66650371 
and heterozygosity for Hph α-thalassaemia mutation was found in the twins and not found in 
any of the other 22 patients.  Further studies are needed to uncover likely additional genetic 
variants that could contribute to the  exceptionally high HbF levels and mild phenotype in these 
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INTRODUCTION 
 Patients who are either homozygous or compound heterozygous for β-thalassaemia 
mutations have intracellular accumulation of free HbA that precipitates and leads to erythroid 
cell apoptosis, ineffective erythropoiesis and haemolysis.  Most of these patients are severely 
anaemic from an early age and require chronic red blood cell (RBC) transfusions (Weatherall & 
Clegg, 2001). 
 Increased HbF production is found in adults with hereditary persistence of fetal 
haemoglobin (HPFH) point mutations in HBG promoters or with HPFH, (HBD HBB)0- or (HBG1 
HBD HBB)0
 Two dizygotic twin young men were homozygous for FSC8 mutation (HBB:c25_26delAA).  
Both were clinically well, had mild microcytic anaemia and almost all haemoglobin produced 
was HbF.  In contrast, among 22 other FSC8 homozygote patients, 4 had thalassaemia 
intermedia phenotype and 18 were transfusion dependent.  We now report genetic 
determinants found in both twins pertaining to their capacity to produce large amounts of HbF.  
Further studies are needed to uncover likely additional genetic variants that can up-regulate 
HbF expression in these patients.      
-thalassaemia deletions.  In addition, three major HbF quantitative trait loci (QTL) 
mediate increased HbF production (Thein & Menzel, 2009).  They are defined by the HBG2 
Xmn1 polymorphism at Chr11p15 (rs7482144), the HBS1L-MYB intergenic polymorphism 
(HMIP) at 6q23 (rs66650371) and the BCL11A intron 2 polymorphism at 2p16 (rs766432).  Their 
alternate or minor alleles are associated with elevated HbF levels.   
 
METHODS 
Blood counts were done using an automated haematology analyser.  Haemoglobin 
analyses were carried out with Variant II cation high-performance liquid chromatography 
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Genomic DNA was extracted from peripheral blood leucocytes by QIAGEN BioRobot EZ1 
workstation with EZ1 DNA kit (QIAGEN, Valencia, CA, USA).  Globin genes and other genetic loci 
of interest were amplified by polymerase chain reaction (PCR), and the purified amplicons were 
subjected to Sanger bidirectional nucleotide sequencing using the ABI Big Dye Terminator Cycle 
Sequencing kit (Applied BioSystems, Foster City, CA, USA) and ABI 3730 DNA Analyser.  HBA 
deletions were assessed by gap-PCR (Tan et al, 2001). 
Molecular diagnoses 
Sentinel single nucleotide polymorphisms (SNPs), rs66650371, rs9399137 and rs766432 
in known HbF QTL were determined by PCR-based amplification refractory mutation system 
(ARMS) (Farrell et al, 2011; Table S.1).   
Multiplex ligation-dependent probe amplification (MLPA) analysis was done on the HBB 
gene cluster including its locus control region (LCR) using the SALSA MLPA KIT P102 HBB kit 
(MRC Holland, Amsterdam, the Netherlands) according to manufacturer’s instructions.  
The haplotype of the HBB globin gene cluster found in Mediterranean populations as 
described by Orkin et al (1982) was determined by the polymorphic profile of 7 restriction sites 
(HBE-HindII, HBG2- HindIII, HBG1-HindIII, 5′ and 3′ HBBP1-HindII, HBB-AvaII and HBB-HinfI) 
using PCR-restriction fragment length polymorphism procedures as previously described 
(Ekwattanakit et al, 2012).  
Haplotype analysis of the HBB globin gene cluster 
 
RESULTS  
 A 21-year old Iraqi-American man was found to have splenomegaly.  He was otherwise 
well, and had never been transfused.  He had mild microcytic anaemia (Hb 123 g/l; MCV 72 fl) 
with slightly increased reticulocyte count (1.9%).  His mean RBC corpuscular haemoglobin 
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(MCH) was 22.9 pg, similar to β-thalassaemia trait.   Haemoglobin analysis by cation exchange 
HPLC showed HbF 97.8% and HbA2 2.2% (Table I).  Matrix-assisted laser desorption ionization 
(MALDI) mass spectrometry revealed the proportion of HBG2/HBG1 at approximately 3/1 to 
4/1, and HBE was not detected (data not shown).  Nucleotide sequencing of his HBB, HBA2, 
HBA1, HBG2 and HBG1 was done.  The patient was homozygous for FSC8 β0
 The proband had a dizygotic twin brother, documented by non-identical SNP genotypes 
at 7 different loci on chromosomes 7, 13, 16 and 19 (Table S.2).  Table I tabulates the clinical 
laboratory results of the proband, his dizygotic twin brother, his older sister and both his 
parents.  The other twin also was homozygous for FSC8 mutation, and their sister and parents 
were heterozygous for the same mutation.   
-thalassaemia 
mutation (Fig. S.1A), heterozygous for Hph α-thalassaemia mutation in his HBA2 
(HBA2:c.95+2_95+6delTGAGG), and homozygous for the G>A HBG2 promoter Xmn1 
polymorphism at rs7482144 (HBG2:c.-211G>A).  Known HPFH mutations were not found in his 
HBG2 and HBG1 promoters.  There was no deletion or duplication involving his HBB locus, as 
shown by MLPA (Fig. S.1B).  His KLF1 gene was sequenced, and no mutation was found (data 
not shown). 
 Both twins were homozygous for HBB cluster haplotype IV, which is found in only 1% of 
the Mediterranean population (Orkin et al, 1982).  Except for HBB-AvaII polymorphism, 
haplotype IV is identical to Senegal haplotype found in sickle cell anaemia patients who have 
relatively high HbF levels (Akinsheye et al, 2011).  The twins’ parents and sister had haplotypes 
I/IV.   
 HBB locus control region (LCR) DNase I hypersensitive site 2 (HS2) core in the proband 
was sequenced from Chr11:5,301,778 – 5,302,235.  No mutation or deletion was found.  He had 
identical purine/pyrimidine repetitive sequences  [ (TA)
HBB cluster locus    
9 (CA)2 (TA)2 CG (TA)10 
 Within the HBD-HBG1 intergenic region, there are multiple cis-regulatory elements 
capable of modulating HBG expression (Fig. S.2).  Overlapping amplicons covering the entire 
]  downstream of 
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14.5 kb intergenic region in the proband were obtained by PCR, and Sanger nucleotide 
sequencing was done.  No deletion was found.  The twin was homozygous for alternate alleles 
of rs10128556 and rs2071348 (Table II, Fig. S.2), which were previously shown to be associated 
with increased HbF in sickle cell anaemia patients and in patients with HbE/β0
 The transcription factor BP1 (DLX4) binding site at 530 bp 5’ to the HBB in the proband 
was found to be homozygous for the common reference sequence, [ (AC)
-thalassaemia 
mutation, respectively (Galarneau et al, 2010; Nuinoon et al, 2010).  He was homozygous for 
the alternate alleles of 19 SNPs, none of which resides within known functional motifs (Fig. S.2,  
Table S.3). 
2 (AT)7 T7 ] (Zoueva et 
al, 2008).   
(1) XmnI polymorphism in the HBG2 promoter on Chr. 11p15 
HbF quantitative trait loci (QTL) 
 Both twins were homozygous for the alternate allele A at rs7482144, also known as the 
XmnI polymorphism at nt –158 in the HBG2 promoter (Table II).   
(2) HMIP polymorphism on Chr. 6q23 
 Both twins and their 3 other immediate family members were homozygous for the 
alternate allele C at the sentinel SNP rs9399137 in HMIP (Table II).  Furthermore, all 5 family 
members were homozygous for the 3-bp deletion, rs66650371, which is in linkage 
disequilibrium with rs9399137 and primarily responsible for mediating this QTL’s effect upon 
HbF expression (Farrell et al, 2011; Stadhouders et al, 2014).  
(3) BCL11A intron 2 polymorphism on Chr. 2p16 
 Both twins and their father were heterozygous for the alternate allele of BCL11A 
intronic SNP rs766432 (Table II) (Menzel et al, 2007a).  There are 3 erythroid specific DNase I 
hypersensitive sites (DHS) within BCL11A intron 2, known as +55, +58 and +62 based on the 
distances in kb between the DHS motif and BCL11A transcription start site (Figure 1) (Bauer et 
al, 2013).  The 3 DHS sites in the proband were sequenced.  The proband was found to be 
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rs1427407, rs1896293 and rs7606173, all known to be associated with elevated HbF levels in 
sickle cell anaemia patients (Figure 1, Table II) (Bauer et al, 2013). 
   
 Table S.4 presents findings on 4 Turkish FSC8 homozygotes.  Two sisters, aged 30 and 32 
years, were transfused sparingly before splenectomy.  No transfusions have been given since 
splenectomy, at age 8 and 11 years, respectively.  Their Hb was 86 and 93 g/l.  Two boys, aged 7 
and 13 years, had a Hb of 77 and 98 g/l, respectively, and neither had been transfused.    
Other FSC8 homozygote patients 
 Table S.5 presents findings on 18 additional transfusion-dependent FSC8 homozygotes.  
Six were Iraqi, 6 Turkish, 2 Moroccan and 4 or were classed as North African 
(Moroccan/Algerian).  Ten had undergone splenectomy.  Fifteen of these transfusion 
dependent patients were homozygous for HBB cluster haplotype IV/IV, and homozygous for 
XmnI polymorphism in the HBG2 promoter, identical to that found in the asymptomatic twins.  
Three other patients, 1 Turkish and 2 North African, were homozygous for haplotype VII/VII, 
and they did not have the XmnI polymorphism in their HBG2 promoter. 
 Table III summarizes the HbF QTL findings among all FSC8 homozygotes.  Both dizygotic 
twins were homozygous for the 3-bp deletion at rs66650371 in HMIP (Table II).  Among the 4 
patients with “mild” phenotype, 3 were heterozygous for the 3-bp deletion, and 1 did not have 
the deletion (Table S.4).  Among the 18 transfusion-dependent patients, 8 were heterozygous 
for the 3-bp deletion, and the other 10 did not have the deletion (Table S.5).  The differences in 
the allele frequencies among these 3 groups of patients are statistically highly significant (P = 
0.0035).      
 
DISCUSSION 
 The FSC8 β0-thalassaemia mutation (HBB:c25_26delAA) was first described in a Turkish 
patient (Orkin & Goff, 1981).  This deletion leads to a premature termination codon TGA at 
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subjected to nonsense-mediated decay resulting in β0
 Gurgey et al (1989) reported 8 Turkish patients homozygous for FSC8 mutation who 
presented as thalassaemia intermedia.  They were homozygous for HBB haplotype IV, 
associated with the Xmn1 polymorphism in HBG2 promoter.  Their age ranged between 6 to 35 
years with Hb 97 ± 10 g/l, MCV 73 ± 2 fl and HbF 98.6 ± 0.2%.  Five had mild thalassaemic facies; 
all had splenomegaly; 6 had undergone splenectomy.   
-thalassaemia.   Homozygotes for this 
mutation usually are transfusion-dependent, and are found in Turkey, Northern Iraq, 
Azerbaijan, Morocco, and their neighbouring regions (Cürük et al, 1992; Kuliev et al, 1994; 
Lemsaddek et al, 2003; Lemsaddek et al, 2004; Al-Allawi et al, 2010; Hamamy & Al-Allawi, 2013; 
Gurgey et al, 1989).  
The dizygotic twins in this report were homozygous for the FSC8 mutation.  Their 
phenotype was the mildest among those reported in the literature, and among 22 other 
patients we have studied.  They have inherited HBB haplotype IV/IV associated with XmnI 
polymorphism in HBG2 promoter, similar to Senegal haplotype found in sickle cell anaemia 
patients with increased HbF.  Fifteen other transfusion-dependent patients also were 
homozygous for haplotype IV (Table III).  Therefore these findings could not account for the 
twins’ exceptionally mild phenotype.   
Genotyping done on skeletal remains of an 8-year old child found in an archaeological 
site in Israel revealed FSC8 homozygosity (Filon et al, 1995).  The site was dated to the Ottoman 
period between 16th and 19th centuries.  The authors surmised that the child must have had 
inherently high HbF production to sustain her survival (Filon et al, 1995).       
 Stress erythropoiesis plays an important role in enhanced HbF production.  For example, 
sickle cell anaemia patients from Eastern Provinces in Saudi Arabia have markedly elevated HbF 
levels, yet their HbS carrier parents, with the same Arab-Indian haplotype and no haemolysis, 
have normal HbF (Miller et al, 1986).  The twins had splenomegaly and minimal reticulocytosis 
consistent with mild stress erythropoiesis.   
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 In studies on the Corfu δβ-thalassaemia deletion in conjunction with β IVS I-5 G>A 
(HBB:c.92+5G>A), a severe β+-thalassaemia mutation, robust HBG mRNA accumulation and 
translation resulting in elevated HbF levels occurred only when HBB mRNA fell below a critical 
threshold (Chakalova et al, 2005).  FSC8 homozygotes have absence of HBB mRNA due to 
nonsense-mediated decay.  This might account for the propensity of all FSC8 homozygotes to 
produce increased HbF.  Alone, this would not explain the twins’ asymptomatic phenotype 
compared with other patients.   
 There are 3 major HbF QTL, on Chr.11p15, 6q23 and 2p16.  Together they account for 
approximately 20-50% of HbF variance in different populations.  However genetic determinants 
accounting for more than half of HbF variance in all populations are yet to be discovered.  The 
twins were (1) homozygous for HBB haplotype IV; (2) homozygous for rs7482144 alternate 
allele on chr.11p15; (3) homozygous for HMIP 3-bp deletion on chr.6q23; (4) heterozygous for 
BCL11A intron 2 QTL on chr.2p16; and (5) heterozygous for Hph α-thalassaemia mutation.  
These genetic variants must be partially responsible for increased HbF expression in the twins 
and in other FSC8 homozygotes.   
Genetic determinants of HbF expression 
 Among patients of African descent with sickle cell anaemia, the Senegal haplotype, 
characterized by rs7482144, have the highest HbF.  The twins were homozygous for HBB 
haplotype IV, which shares 6 identical and consecutive polymorphisms from HBE to HBBP1 with 
the Senegal haplotype.  The proband has inherited the same purine/pyrimidine repetitive 
sequence within LCR HS2 as in the Senegal haplotype (Öner et al, 1992), and rs2071348 and 
rs10128556 within the HBD-HBG1 intergenic region known to be associated with elevated HBG 
expression (Galarneau et al, 2010; Nuinoon et al, 2010).  There were 3-4 times more HBG2 than 
HBG1 globin chains in both twins, as predicted by the presence of rs7482144.  The pathways 
whereby haplotype IV is associated with HbF up-regulation are presently not known. 
 The most important functional motif for HMIP is the 3-bp deletion, rs66650371 in an 
enhancer capable of regulating MYB expression (Farrell et al, 2011; Stadhouders et al, 2014).  In 
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and RUNX1.  The 3-bp deletion interferes with normal spatial orientation for DNA-protein 
binding and/or protein-protein interactions, leading to decreased enhancer activity and down-
regulation of MYB expression.  MYB can transactivate KLF1 expression, and also plays an 
important role in cellular proliferation and haematopoiesis (Jiang et al, 2006; Bianchi et al, 
2010; Menzel et al, 2007b; Ganesh et al, 2009).  Both twins were homozygous for this 3-bp 
deletion (Tables II & III).  This has to be one of the pivotal genetic determinants accounting for 
the twin’s heightened HbF production.                              
 BCL11A is an essential transcriptional repressor of HBG expression.  Both twins were 
heterozygous for this QTL in BCL11A intron 2.  Their mother and sister were homozygous for 
the same QTL, and yet their HbF levels were merely 4 – 5 % (Table I).  Two patients (7 and 22 in 
Table S.5) were also homozygous for this QTL, and yet they were transfusion dependent.  
Therefore, BCL11A polymorphisms are not responsible for the twins’ exceptionally high HbF.        
 The twins were heterozygous for a deletion of 5-bp (–TGAGG) in the IVS-1 donor splice 
site in HBA2 (HBA2:c.95+2_95+6delTGAGG), the more highly expressed of the two HBAs.  In β-
thalassaemia patients, the co-inheritance of α-thalassaemia reduces HBA to non-HBA synthetic 
imbalance, and results in less unpaired HBA that can precipitate and damage the erythroid cell.  
The inheritance of α-thalassaemia in the twins in conjunction with their HbF QTL alternate 
alleles should aid in the preferential survival of many more RBC with high HbF expression.  Of 
note is Patient 12 who had single HBA deletion and severe disease phenotype (Table S.5).     
 To summarize, homozygosity for the 3-bp deletion in HMIP and heterozygosity for the 
Hph α-thalassaemia mutation in HBA2 were the 2 genetic determinants found only in the 
asymptomatic twins and not found in any of the other 22 FSC8 homozygote patients.  These 2 
genetic variants are most likely among the essential genetic factors contributing to the twins’ 
uniquely high HbF expression.  Future investigations by genetic approaches, such as whole 
genome sequencing and transcriptome expression, to study and compare FSC8 homozygotes 
with markedly disparate phenotypes should identify additional genetic variants that are 
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Table I.  Haematological Findings and Globin Genotypes 
Relationship Father Mother Sister Proband Twin brother 
Age  (years) 53 50 24 21 21 
Hb  (g/l) 127 129 124 123 133 
Hct  (%) 41.8 42.1 40.8 38.9 40.8 
MCV  (fl) 65 76 74 72 73 
MCH  (pg) 19.8 23.4 22.6 22.9 23.9 
MCHC  (g/l) 304 306 304 316 326 
Reticulocyte count 0.87% 1.14% 0.38% 1.92% 1.52% 
WBC  (109 7.1 /l) 8.1 5.6 12.5 10.7 
Platelets  (109 145 /l) 236 197 147 143 
Hb A 90% 90% 88% --- --- 
Hb A 5.1% 2 5.0% 5.1% 2.2% 2.6% 
Hb F 3.3% 4.3% 5.4% 97.8% 97.4% 
β-Globin genotype 
Codon 8 (-AA) 
heterozygous 
Codon 8 (-AA) 
heterozygous 
Codon 8 (-AA) 
heterozygous 
Codon 8 (-AA) 
HOMOZYGOUS 
Codon 8 (-AA) 
HOMOZYGOUS 
α-Globin genotype ( α α / α α ) ( α
HpH 
( αα / α α ) 
HpH 
( αα / α α ) 
HpH 
( αα / α α ) 
HpH 
α / α α ) 
HBB globin gene 
cluster haplotype 
I / IV I / IV I / IV IV / IV IV / IV 
Hb, haemoglobin concentration; Hct, haematocrit; MCV, mean corpuscular volume; MCH, mean corpuscular haemoglobin; MCHC, mean cell haemoglobin 
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Table II.  SNP Genotypes at 3 HbF QTL 







Father Mother Sister Proband 
Twin 
brother 
HBB cluster  
on Chr.11p15 
HBP1 intron 2 
rs10128556 5,263,683 C T    T / T  
rs2071348 5,264,146 T G    G / G  
HBG2 
promoter 
rs7482144 5,276,169 G A G / A G / A G / A A / A A / A 
HMIP  
on Chr.6q23 






TAC deletion del / del del / del del / del del / del del / del 
rs9399137 135,419,018 T C C / C C / C C / C C / C C / C 
BCL11A intron 2  
on Chr.2p16 
DHS +62 
rs1427407 60,718,043 G T    G / T  
rs1896293 60,718,848 G T    G / T  
 rs766432 60,719,970 A C A / C C / C C / C A / C A / C 
DHS +58 
rs6706648 60,722,040 C T    C / C  
rs6738440 60,722,241 A G    A / A  
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- 60,724,766 
DHS +55 rs7606173 60,725,451 G C    G / C  
SNP alternate alleles are coloured red. 
SNP ID, single nucleotide polymorphism identification; HMIP, HBS1L-MYB intergenic polymorphism.  
 
Table III.  Summary of HbF QTL in FSC8 Homozygotes 
 













(N = 18) 
 
P-value 
Xmn I on Chr. 11p15 
 
rs7482144 
A / A 2 4 15 
0.69 G / A 0 0 0 
G / G 0 0 3 
HMIP on Chr. 6q23 
 
rs66650371  or  3-bp deletion 
del / del 2 0 0 
0.0035 WT / del 0 3 8 
WT / WT 0 1 10 
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rs766432 A / C 2 2 7 
A / A 0 2 9 
 
Pearson Chi-square test was used to compare HbF QTL genotype frequencies among 3 groups of patients. 
Statistical analyses were performed using R Statistical Software (http://www.r-project.org/).  P-values were obtained 
from the simulation. 
SNP alternate alleles are coloured red. 
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FIGURE LEGEND 
Figure 1 The figure shows ~8.5 kb of BCL11A intron 2 region encompassing the 3 
erythroid-specific DHS (Bauer et al, 2013).  The numbers on the first row represent hg19 Chr2 
positions (http://hgdownload.cse.ucsc.edu/goldenPath/hg19/bigZips/).  On the second and 
third rows, each perpendicular bar represents a single SNP found in the proband.  Red and blue 
bars represent heterozygosity for the SNP alternate allele.  The black bars represent 
homozygosity for the SNP reference allele.  The red bar represents homozygosity for the SNP 
alternate allele (see Table II).  The green shaded areas represent the 3 DHS, and the numbers 
on the bottom row represent distances in kb from BCL11A transcription start site (Bauer et al, 
2013).  They are DHS +62, Chr2:60,717,492-60,718,860; DHS +58, Chr2:60,721,411-60,722,674; 
and DHS +55, Chr2:60,724,802-60,726,084.  The black areas represent Chip-seq signals of 
GATA1 in human peripheral blood-derived erythroblasts, from ENCODE data 
(https://www.encodeproject.org/experiments/ENCSR000EXP/). 
DHS, DNase 1 hypersensitive site; SNP, single nucleotide polymorphism.  
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